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Abstract
Studies of expression quantitative trait loci (eQTLs) offer insight into the molecular mechanisms 
of loci that were found to be associated with complex diseases and the mechanisms can be 
classified into cis- and trans-acting regulation. At present, high-throughput RNA sequencing 
(RNA-seq) is rapidly replacing expression microarrays to assess gene expression abundance. 
Unlike microarrays that only measure the total expression of each gene, RNA-seq also provides 
information on allele-specific expression (ASE), which can be used to distinguish cis-eQTLs from 
trans-eQTLs and, more importantly, enhance cis-eQTL mapping. However, assessing the cis-
effect of a candidate eQTL on a gene requires knowledge of the haplotypes connecting the 
candidate eQTL and the gene, which cannot be inferred with certainty. The existing two-stage 
approach that first phases the candidate eQTL against the gene and then treats the inferred phase 
as observed in the association analysis tends to attenuate the estimated cis-effect and reduce the 
power for detecting a cis-eQTL. In this article, we provide a maximum-likelihood framework for 
cis-eQTL mapping with RNA-seq data. Our approach integrates the inference of haplotypes and 
the association analysis into a single stage, and is thus unbiased and statistically powerful. We also 
develop a pipeline for performing a comprehensive scan of all local eQTLs for all genes in the 
genome by controlling for false discovery rate, and implement the methods in a computationally 
efficient software program. The advantages of the proposed methods over the existing ones are 
demonstrated through realistic simulation studies and an application to empirical breast cancer 
data from The Cancer Genome Atlas project.
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Expression quantitative trait loci (eQTLs) mapping searches across the genome for variants 
that regulate expression levels of messenger RNAs. Studies of eQTLs can not only discover 
the genetic basis underlying the variation in gene expression but also decipher molecular 
mechanisms of loci that were found to be associated with complex diseases by genome-wide 
association studies (GWAS) (Cookson et al. 2009). At present, high-throughput RNA 
sequencing (RNA-seq) is rapidly replacing expression microarrays to assess gene expression 
abundance. To date, The Cancer Genome Atlas (TCGA) project has collected RNA-seq data 
on >5,000 samples over 17 cancers. These data hold the potential to characterize the 
functional roles of GWAS hits (Welter et al. 2014), which can later be translated into 
clinical benefits such as cancer treatments. However, traditional methods for eQTL mapping 
were developed for microarray expression data (Kendziorski and Wang 2006) and may no 
longer be appropriate for RNA-seq data.
Compared with microarrays that only measure the total expression of each gene, one 
important feature of RNA-seq is its ability to measure allele-specific expression (ASE). In a 
diploid individual, each chromosome consists of a paternal copy and a maternal copy, and 
each gene comprises a paternal allele and a maternal allele. The expression of each allele of 
a gene is referred to as its ASE, which has been used to distinguish between cis- and trans-
eQTLs. By definition, a cis-eQTL is located on the same chromosome as the target gene 
(e.g., transcriptional factor binding site of the gene) and the DNA variation on the paternal 
(or maternal) chromosome only influences the transcription process of the paternal (or 
maternal) gene allele. By contrast, a trans-eQTL can be located anywhere in the genome and 
influences the transcription of the target gene by modifying the abundance or activity of a 
protein that regulates the gene; this regulation does not discriminate between the two alleles. 
Therefore, a cis-regulation typically leads to differential ASE between the two alleles of an 
individual whereas a trans-regulation generally results in the same amount of expression 
change. Such a pattern of ASE can be used to distinguish cis-eQTLs from trans-eQTLs. 
More importantly, the difference in ASE offers another layer of information on top of the 
total gene expression to enhance cis-eQTL mapping.
With RNA-seq data, the ASE can be measured by sequence reads that are unambiguously 
mapped to each of the two gene alleles. For an individual, the usable reads must overlap 
with at least one exonic single nucleotide polymorphism (SNP) at which the individual 
carries a heterozygous genotype. In Figure 1(a), we illustrate the quantification of ASE for a 
hypothetical gene with two exons and two exonic SNPs. In individual (i), four and two reads 
harbor alleles A and T, respectively, at the first exonic SNP, and four and two reads harbor 
alleles A and G, respectively, at the second exonic SNP. Thus, the ASE is estimated to be 
eight and four for gene alleles containing the haplotypes A-A and T-G, respectively. In 
individual (ii), only the eight reads overlapping with the first SNP can be counted into the 
ASE measure. In individual (iii), no read can be counted into ASE.
Using the ASE, cis-eQTL mapping assesses whether one allele of a (biallelic) SNP is 
associated with a higher or lower ASE than the other allele. We use Figure 1(a-b) to 
HU et al. Page 2













illustrate this process. In individual (i), after the haplotypes are inferred as C-A-A and T-T-
G and the ASE is quantified as above, alleles C and T of the candidate cis-eQTL are linked 
with the ASE measurements of eight and four, respectively (Figure 1[a]). Because allele C is 
associated with a higher ASE than allele T, this SNP is likely a cis-eQTL (Figure 1[b]). Note 
that only individuals heterozygous at the candidate eQTL provide information for cis-eQTL 
mapping. The ASE measured as above is only comparable within individuals, with one ASE 
measurement serving as the control for the other, but not comparable across individuals.
Evidently, the phase information is essential to link the ASE with the alleles of the candidate 
cis-eQTL. Many algorithms (Stephens et al. 2001; Browning and Browning 2009; Li et al. 
2010; Delaneau et al. 2012) have been developed to infer the haplotype phase from the 
genotypes of unrelated individuals. It is often reasonable to assume that the inferred phase is 
accurate within the gene body, because genes are relatively short (Flicek et al. 2011), and 
RNA-seq reads that span over two or more SNPs provide direct information on the phase. 
However, the phasing accuracy tends to deteriorate when the haplotypes extend to the 
candidate eQTL, which is often located in an inter-genic region and can be a few hundred 
kilobases (kb) away from the gene. Incorrectly linking the SNP alleles with the ASE will 
greatly compromise the power of cis-eQTL mapping.
Besides the ASE, the total gene expression, which is measured by the total read count 
(TReC) (i.e., the total number of reads mapped to the gene), also provides information for 
cis-eQTL mapping. As shown in Figure 1(c), the individual with genotype CC has the 
highest TReC followed by the individual with CT and then TT, and such a pattern is 
consistent with the aforementioned observation that allele C is associated with a higher ASE 
than allele T. Note that the quantification of TReC is not confined to reads that overlap with 
SNPs showing heterozygous genotypes. Thus, the TReC is generally much greater than the 
sum of the two ASE measurements and can be compared across individuals.
Traditional methods for eQTL mapping, which were originally developed for microarray 
expression data, have been applied to the RNA-seq TReC data after normalization (Pickrell 
et al. 2010). These methods do not exploit the ASE information, ignore the digital nature of 
the read count data, and cannot distinguish between cis- and trans-eQTLs. To incorporate 
both the ASE and TReC data available from RNA-seq for cis-eQTL mapping, Sun (2012) 
proposed a two-stage approach that first phases the candidate eQTL against the target gene 
and then treats the inferred phase as observed in assessing the cis-effect. This approach, 
pertaining to single imputation in the missing data literature, has two limitations. First, the 
phasing process disregards the gene expression, which is potentially informative about the 
missing phase, especially for a true cis-eQTL. Second, the downstream association analysis 
ignores the uncertainties in the inferred phase. Consequently, the two-stage approach tends 
to attenuate the estimated cis-effect and reduce the power for detecting a cis-eQTL. A 
further challenge, which has not been addressed in previous work, remains to develop 
computationally efficient methods to evaluate the significance of eQTL findings when 
multiple, correlated SNPs are tested for each gene.
In this article, we propose a maximum-likelihood approach for cis-eQTL mapping that 
incorporates both the ASE and TReC data. Unlike Sun (2012), our approach integrates the 
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phasing of the candidate eQTL and the association analysis into a single stage. Thus, our 
maximum-likelihood estimators (MLEs) for cis-effects are unbiased and statistically 
efficient in the sense that the corresponding test of association is the most powerful among 
all valid tests based on the same data and same assumptions. Within the maximum-
likelihood framework, we develop a five-step pipeline (Figure 2) for performing the 
comprehensive analysis of all local eQTLs for all genes in the genome. Here, we restrict the 
candidate eQTLs to the local SNPs because cis-eQTLs are mostly local and the gene body 
contains little information about the phase of a SNP if the SNP is too distant. The five steps 
of our pipeline are (1) testing every candidate eQTL for association with the expression of a 
gene (referred to as a gene-SNP pair) and focusing on the SNP with the minimum p-value 
(referred to as the minimum-p SNP) for each gene, (2) assessing the significance of each 
minimum-p SNP, (3) detecting eQTLs among genome-wide minimum-p SNPs by 
controlling for false discovery rate (FDR), (4) distinguishing between cis- and trans-acting 
regulations at detected eQTLs, and (5) estimating the effect sizes at detected eQTLs. We 
implement the proposed methods, including an ultra-fast permutation process for step (2), in 
a computationally efficient program. We show in realistic simulation studies that the 
proposed approach is more powerful than the two-stage approach and the use of the TReC 
data alone. We further demonstrate the usefulness of the new methodology and software 
program in an application to the breast cancer data from TCGA.
2. METHODS
2.1 ASE Model
Suppose that each SNP is biallelic with allele values 0 and 1. Thus, each haplotype is a 
unique sequence of 0s and 1s on one copy of a chromosome. We denote the  possible 
haplotypes at the  exonic SNPs within a gene by , and denote the ordered 
diplotype consisting of haplotypes  and  by , where m, n = 1, …, . 
For the reasons mentioned earlier, we assume that  is known. For a 
candidate eQTL, let G be the genotype, which is the number of allele 1, and let G1 be the 
phase, which is the number of allele 1 on the same chromosomal copy as . The candidate 
eQTL can be outside or inside the gene body. We focus on the former case, under which G1 
is unknown for individuals who are heterozygous at the candidate eQTL; the latter case is 
trivial as G1 would be known. We use  to infer G1 by exploiting the linkage disequilibrium 
(LD) between the exonic SNPs and the candidate eQTL. To this end, we consider the joint 
distribution of the M =  + 1 SNPs. Let H = (hk , hl) be the ordered diplotype at the M 
SNPs, where k, l = 1, …, K indexing the K possible haplotypes. Write πk = Pr(h = hk ) and π 
= (π1, …, πK)′, where ν′ denotes the transpose of the vector ν. Under Hardy-Weinberg 
equilibrium (HWE), the frequency of H = (hk, hl) is πkπl, denoted by Pπ{H = (hk, hl)}. Both 
H and G1 are unknown. Once H is inferred as (hk, hl), G1 is simply the value of hk in the 
position of the candidate eQTL.
The ASE data are represented by the number of allele-specific reads mapped to  and the 
sum of the two allele-specific read counts, denoted by R1 and R, respectively. Note that R1 
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pertains to the same chromosomal copy as G1. Because R1 is not comparable across 
individuals, we model the conditional probability of R1 = r1 given R = r by a beta-binomial 
distribution with a success rate pk,l and a dispersion parameter ψ,
where
(1)
with βA characterizing the effect of G1 on R1. The beta-binomial distribution is an extension 
of the binomial distribution Bin(r, pk,l) to allow for over-dispersion. When there is no allele-
specific read, i.e., r = 0, we set PβA,ψ(r1|r, (hk, hl)) = 1. Note that the covariates (e.g., 
intercept term, demographical or environmental factors) are ignored, because the 
comparison is between R1 and R − R1 within an individual so that any covariate effect is 
canceled out.
Because H (or equivalently, G1) may be missing, the likelihood based on the observed data 
(R1i, Ri, Gi, ) (i = 1, …, N) involves a summation:
(2)
where Hi ~ (Gi, ) denotes the set of His that are compatible with Gi and . If Gi = 1, such 
a set consists of two elements, {(1, ), (0, )} and {(0, ), (1, )}. If Gi = 0 or 2, then 
Hi is uniquely determined. As noted earlier, only individuals with Gi = 1 and Ri > 0 provide 
information about the effect size βA. However, all individuals with Ri > 0 are used for 
estimating the over-dispersion parameter ψ, and all, including those with Ri = 0, are used for 
estimating the haplotype frequencies in π. We refer to (2) as the ASE model. The two-stage 
approach (Sun 2012) can be viewed as a special case of (2) in that the set Hi ~ (Gi, ) only 
contains the inferred value and Pπ(Hi) factors out.
2.2 TReC and TReCASE Models
Denote the TReC of the gene by T. We adopt the TReC model of Sun (2012) for assessing 
the effect of genotype G on T. We reformulate his TReC model in this section to conform to 
the notation in this article. Let X be a set of p covariates including the unit component. The 
probability of T = t given the genotype G = g and the covariates X = x is formulated through 
a negative-binomial distribution with mean µx,g and a dispersion parameter φ:
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where Γ(.) is the Gamma function. The negative-binomial distribution is a generalization of 
the Poisson distribution to allow for over-dispersion. The covariate-adjusted effect of G on 




The form of Ƶ(g, βT) reflects the additive genetic effect. To see this, we first write log(µx,0) 
= γ′x and log(µx,2) = γ′x+βT, from which we obtain βT = log(µx,2/µx,0). Then, it follows from 
the additive effect that log(µx,1) = log(µx,0 +µx,2)−log 2 = log(µx,0)+log(1+µx,2/µx,0)−log 2, 
which satisfies (3) and (4) after replacing µx,2/µx,0 by exp(βT). The additive model is the 
most commonly used in eQTL studies. Indeed, a cis-effect is additive by definition. Finally, 
the likelihood based on the data (Ti, Xi, Gi) (i = 1, …, N) takes the form
(5)
When an eQTL cis-regulates the gene expression, we have βA = βT. To show this, we 
introduce υ1 and υ0 as the mean ASE corresponding to alleles 1 and 0, respectively, of the 
candidate eQTL at the baseline of X. For individuals with G = 1 and G1 = 1, we have pk,l = 
υ1/(υ1 + υ0) and then βA = log{pk,l/(1 − pk,l)} = log(υ1/υ0); for those with G = 1 and G1 = 0, 
we have pk,l = υ0/(υ1 + υ0) and βA = log{(1 − pk,l)/pk,l} = log(υ1/υ0). On the other hand, we 
have βT = log(µx,2/µx,0) = log{2υ1/(2υ0)}, where the second equation follows from the 
additivity assumption. Therefore, we obtain βA = βT and denote them by a common effect 
size β. To combine the ASE and TReC data for inference on β, we employ the joint 
likelihood
(6)
We refer to (6) as the TReCASE model. Again, the two-stage approach using the combined 
data is a special case of (6). A trans-eQTL implies that βT ≠ 0 and βA = 0. In that case, the 
TReCASE model is not appropriate because the ASE data provide no information for the 
association but simply introduce noise. The TReC model alone should be used for trans-
eQTL mapping.
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2.3 A Measure of Phasing Accuracy
In theory, the ASE and TReCASE models allow the use of all exonic SNPs in the target 
gene to predict the phase of a candidate eQTL. In practice, there may be a significant 
number of exonic SNPs, which would form a large pool of haplotypes and cause some 
haplotype frequencies too small to be estimated. To balance between the predictive power 
and the numerical stability, we select a small number of exonic SNPs that provide the best 
prediction. In this article, we set  to four following much of the literature (de Bakker et al. 
2005; Nicolae 2006; Lin et al. 2008). To guide the selection of exonic SNPs, we develop a 
measure, called Rsq, to quantify the amount of information in a given set of exonic SNPs for 
predicting the phase; see Appendix A for details. Rsq takes values between 0 and 1, with 0 
and 1 indicating that the set of exonic SNPs provide none and complete information, 
respectively. For a candidate eQTL, we evaluate all sets of  exonic SNPs and select the 
one with the largest value of Rsq.
2.4 Testing A Gene-SNP Pair
The genome-wide scan of gene-SNP pairs involves tens of thousands of genes and hundreds 
or thousands of local candidate eQTLs for each gene. Without any prior knowledge about 
the cis or trans mechanism for each of the massive gene-SNP pairs, we apply the TReC and 
TReCASE models in parallel. The association testing may be performed by the Wald or 
likelihood-ratio statistic based on the likelihood functions (5) and (6). However, the 
calculation of these statistics requires solving for the MLEs of all parameters iteratively for 
each gene-SNP pair, and hence entails a considerable computational burden. By contrast, the 
score statistics (derived in Appendix B) are computationally more efficient and numerically 
more stable, as it only requires solving for the nuisance parameters (i.e., ψ, π, γ, and φ). 
With the TReC model, in particular, the nuisance parameters only need to be solved once for 
all tests pertaining to one gene. Thus, we employ the score statistic of each model to produce 
a p-value for each gene-SNP pair. Both tests have correct type I error even when the 
additivity assumption for the TReC model or the cis-regulation assumption for the 
TReCASE model does not hold, because under the null hypothesis there does not exist any 
association between the SNP and the gene expression (either ASE or total expression). 
Violation of these assumptions only affects the power. When the effect is cis (hence 
additive), the test based on the TReCASE model is the most powerful among all valid tests 
that use the same information. When the effect is trans and additive, the test based on the 
TReC model is the most powerful. Due to LD, several SNPs can be found to be associated 
with the expression of a gene by each model. To reduce such redundancy, we focus on the 
minimum-p SNP. Note that the TReC and TReCASE models may yield different minimum-
p SNPs for the same gene.
2.5 Assessing the Significance of the Minimum-p SNP
Due to multiple testing, the score-based p-value at the minimum-p SNP is no longer 
indicative of the significance level. In addition, such p-values are not comparable across 
genes, as different genes have different numbers of local SNPs. To evaluate the significance 
of the minimum-p SNPs, we propose a permutation process that is tailored to the score 
statistics and features ultra-fast computation. We permute the dataset by fixing (T, X, R1, R), 
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shuffling G and  as a whole among the individuals, and then randomly switching  and 
 in  of an individual. Because the nuisance parameters have been 
estimated without reference to the genetic association in the original dataset, they do not 
need to be re-estimated in the permuted datasets in which the association is altered. Thus, 
the analysis of the permuted datasets only involves simple re-evaluation of the cross-
products between (T, X, R1, R) and (G, ) in the score statistics. This is fundamentally 
different from the traditional permutation process employed by Sun (2012), which repeats 
exactly the same (iterative) analysis for the permuted datasets as for the original one. We 
generate B permuted datasets (e.g., B = 5, 000) and calculate the permutation p-value by 
taking the proportion of permuted datasets that generate smaller minimum p-values than the 
observed one.
2.6 Detecting eQTLs Among Genome-Wide Minimum-p SNPs by FDR Control
We adopt the method of Storey and Tibshirani (Storey and Tibshirani 2003) for estimating 
FDR. Specifically, for any p-value cutoff pc, the FDR is estimated by p0pcNtotal/NeQTL, 
where Ntotal is the total number of minimum-p SNPs, NeQTL is the number of those with 
permutation p-values ≤ pc, and p0 is the expected proportion of minimum-p SNPs having 
null effects and is calculated as two times the proportion of minimum-p SNPs with 
permutation p-values ≥ 0.5. We explore over a fine grid of cutoffs and select the one that 
generates the desired FDR, e.g., 5% or 10%. Then, the minimum-p SNPs whose permutation 
p-values lower than the final cutoff are declared as eQTLs. When the procedure is applied to 
the minimum-p SNPs from the TReC and TReCASE models separately with the same FDR, 
the combined minimum-p SNPs are also controlled for that FDR level.
2.7 Distinguishing Between cis and trans Mechanisms at eQLTs
After an eQTL is identified, the mechanism can be determined by the following cis-trans 
test. Let βA = β and βT = β + α. The hypotheses are written as
We employ a score statistic (derived in Appendix B), which is computationally more 
efficient and numerically more stable than the likelihood-ratio statistic adopted by Sun 
(2012).
Up to this point, the TReC and TReCASE models work independently and may identify 
different eQTLs for the same gene. The cis-trans tests at the two eQTLs may yield the same 
or different conclusions. If both eQTLs are determined to be cis, we only retain the one 
identified by TReCASE, in consistent with our focus on only one cis-eQTL for a gene. 
Likewise, if both eQTLs are established to be trans, we only retain the one identified by 
TReC. If one eQTL is determined to be cis and another trans, we keep both for future 
validation, as a gene can be subject to different regulations.
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2.8 Estimating Effect Sizes of eQTLs
For a detected eQTL, the effect sizes in the ASE, TReC and TReCASE models can be 
estimated by maximizing the likelihood functions (2), (5) and (6), respectively. Note that, 
although the ASE model on its own is not used in the steps described in Sections 2.4-2.7, its 
effect size offers a unique insight into the ASE data alone. Because of missing phases, the 
maximization of (2) and (6) can be carried out by the expectation-maximization (EM) 
algorithms described in Appendix B. The maximization of (5) can be achieved by a standard 
Newton-Raphson algorithm. By the classical likelihood theory, the MLEs of the effect sizes 
are consistent, asymptotically normal and asymptotically efficient. Their variances can be 
estimated by the Louis formula (Louis 1982), as provided in Appendix B.
3. SIMULATION STUDIES
We carried out extensive simulation studies to evaluate the performance of the proposed and 
two-stage methods in realistic settings. To make a fair comparison between the two 
approaches, we considered a phasing method for the two-stage approach that uses the same 
amount of information as the proposed approach. Specifically, the method selects the 
exonic SNPs that yield the maximum Rsq for a candidate eQTL, and infers the diplotype Hi 
for the ith individual by the one that corresponds to the largest  among all H ~ (G, 
), where  is obtained by maximizing (7) in Appendix A. In Supplementary Method S1, 
we proved that treating the inferred phase as observed in the ASE model yields a valid test 
of the hypothesis H0 : βA = 0, provided that  is independent of R1 and R. We refer to the 
proposed maximum-likelihood approach and the two-stage (imputation) approach as MLE 
and IMP, respectively. As a benchmark, the approach using the true phase is also included 
and referred to as TRUE. We set the nominal significance level to be 0.05, which is realistic 
because the commonly used FDR values of 5% and 10% correspond to the p-value cutoff of 
0.023 and 0.062 in our analysis of TCGA breast cancer data.
The first study was focused on the effect size estimation and association testing at a cis-
eQTL, when the four exonic SNPs are fixed. We generated genotype data for various sets of 
five SNPs according to the LD patterns observed in the TCGA breast cancer data 
(Supplementary Table S1). For each SNP set, we chose one SNP to be the cis-eQTL, leaving 
the other four to be exonic SNPs. The Rsq values of the exonic SNPs for phasing the cis-
eQTL range from 0.56 to 0.93, which represent a wide spectrum of phasing accuracy 
according to the empirical distribution of Rsq values (Figure 6). Given the cis-eQTL, the 
expression data were generated from the association models, whose nuisance parameters 
were set at typical values observed in the TCGA data. Specifically, the TReC T was 
simulated from a negative-binomial distribution with µX,G = 900 × exp{0.1X + Ƶ(G, βT)} 
and φ = 0.2, where X was a normal random variable with mean zero and variance one. Then, 
R was obtained as the integer part of 0.034 × T, where 0.034 was the average proportion of 
TReC that were allele-specific, and R1 was simulated from a beta-binomial distribution with 
pk,l in (1) and ψ = 0.05. We generated 79 subjects (unless otherwise specified) for each 
dataset, which was the sample size of the TCGA data we analyzed. We applied the 
TReCASE model with the MLE, IMP and TRUE methods, and summarized the results in 
Table 1. As expected, MLE is virtually unbiased in all cases, and the standard error 
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estimates accurately reflect the variability of the effect size estimates. The type I error rates 
of MLE are slightly greater than the nominal significance level of 0.05 due to the small 
sample size of 79. They are much closer to 0.05 when the sample size was increased to 500 
(Supplementary Table S2). As predicted by our theory, IMP yielded proper type I error 
under the null hypothesis. In the presence of association, however, the estimates of β 
produced by IMP are seriously biased towards zero, especially when Rsq is low. 
Consequently, IMP is uniformly less powerful than MLE; the power difference can be seen 
more clearly in Figure 3. As Rsq approaches 1, both MLE and IMP are nearly as powerful as 
TRUE. We also applied the ASE model to the same data, whose results show similar 
patterns (Supplementary Table S3 and Supplementary Figure S1).
The second simulation study was designed to assess the validity and power of using the 
minimum-p SNP and the proposed permutation process. Unlike the first study, we generated 
the genotypes for all the exonic and local SNPs (i.e., within 200 kb of the gene) in various 
gene regions (Supplementary Table S4) via GWAsimulator (Li and Li 2008), which can 
mimic the minor allele frequencies (MAF) and LD patterns observed in the TCGA data. We 
selected a true cis-eQTL for each gene, and simulated the expression data in the same 
manner as in the first study. To significantly speed up the computation, we pruned out 
redundant SNPs that were in strong LD with others, so that the remaining SNPs have 
pairwise Pearson correlation coefficients less than 0.9. Note that the true cis-eQTL may be 
pruned out as well. We employed the TReC and TReCASE models; for the TReCASE 
model, we applied the MLE, IMP and TRUE methods. All the SNPs in and flanking a gene 
were scanned for association with the gene expression, and in the MLE and IMP methods, at 
most four exonic SNPs were selected for informing the phase of a candidate eQTL. Table 2 
summarizes the characteristics of the minimum-p SNPs obtained by various methods. For all 
genes, the minimum-p SNPs yielded by MLE are in stronger LD with the true cis-eQTLs 
than those by IMP and by TReC. We used the proposed permutation process to assess the 
significance of the minimum-p SNPs in all methods. In the absence of any genetic effect, the 
permutation p-values are distributed uniformly between 0 and 1 (Supplementary Figure S2), 
confirming the validity of the permutation process even for the small sample size. In the 
present of cis-effects, MLE is uniformly more powerful than IMP and TReC (Figure 4), and 
is as powerful as TRUE for gene MAP7D1 whose average value of Rsq at the minimum-p 
SNPs is as high as 0.80 (Table 2). When Rsq decreases to 0.4 and below, MLE tends to have 
lower power than TReC (Supplementary Figure S3). This is not surprising because, in such 
cases, the uncertainties about the phase overweigh the information contained in the ASE 
data and incorporating the ASE data even hurt the power from using the TReC data alone.
In the third simulation study, we investigated the MLE and IMP methods in distinguishing 
between cis- and trans-eQTLs, using the five-SNP settings in the first study. To examine the 
type I error of the cis-trans test, we considered various cis-effect sizes. As shown in Figure 
5, IMP tends to generate inflated type I error (i.e., declaring excessive eQTLs to be trans), 
especially when Rsq is low and the cis-effect sizes are large. This is because IMP generally 
yields biased estimates for βA, thereby creating a difference between βA and βT. By contrast, 
MLE produced reasonable type I error rates in all cases, although a slight inflation can be 
observed due to the small sample size of 79. We then assessed the power of the cis-trans test 
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by simulating trans-effects, which implies that βA = 0. As shown in Supplementary Figure 
S4, IMP has the same power as TRUE, because the phasing does not matter when βA = 0; 
note that IMP has accurate control of type I error in this particular case. MLE lost power 
relative to IMP and TRUE due to its enlarged variance to account for phasing uncertainty, 
but the power loss is very modest. We also assessed the power of the cis-trans test 
conditional on βA ≠ 0, whose alternative hypothesis (βA ≠ 0 and βA ≠ βT), although 
corresponding to neither cis- nor trans-effect, may exist in reality through other 
mechanisms. Supplementary Figure S4 displays the power curves when βA was set to 0.5. 
Now that the phasing does matter, IMP has a shifted power curve compared to MLE and 
TRUE; the minimum power is not attained at the null of βT = βA = 0.5 but somewhere below 
0.5.
4. APPLICATION TO TCGA DATA
We performed an analysis of local eQTLs (within 200 kb of a gene) for the genome-wide 
expression in 79 breast cancer (OMIM114480) patients from TCGA, using the RNA-seq 
data collected from the normal breast tissues only. Although tumor tissues are more relevant 
to a cancer, studying normal tissues from cancer patients is also important because it 
provides a baseline for comparison with what happened in tumor tissues. The 79 European 
females were genotyped at ~1 million SNPs by the Affymetrix 6.0 arrays and imputed 
against the European population (EUR) in the 1000 Genomes Project (The 1000 Genomes 
Project Consortium 2012) via MACH (Li et al. 2010), reaching a total of ~36 million SNPs. 
The TReC and ASE of 19,048 autosomal genes were derived from the RNA-seq data by the 
R packages asSeq (Sun 2012) and isoform (http://www.bios.unc.edu/~weisun/software/
isoform.htm). We note that using the imputation-augmented SNP set greatly increased the 
number of reads that can be counted into the ASE measurements. Supplementary Method S2 
has more details on the processing of the RNA-seq data.
We restricted the candidate eQTLs and the exonic SNPs used for phase prediction to 
common SNPs with MAF ≥ 5%. By this criterion, the number of candidate eQTLs per gene 
varied from 7 to 15,536, with a median of 911, and the number of exonic SNPs per gene 
varied from 1 to 14,314, with a median of 53. As in the second simulation study, we pre-
pruned the SNPs, which resulted in median numbers of 373 (ranging from 1 to 6,898) and 
21 (ranging from 1 to 6,282) for candidate eQTLs and exonic SNPs, respectively. The TReC 
model was applied to all the 19,048 genes, including as covariates the log-transformed total 
read count per sample and three principal components calculated from the standardized 
TReC data. For numerical stability, we ran the TReCASE model for a candidate eQTL only 
if at least five samples who are heterozygous at the candidate eQTL had five or more allele-
specific reads. Thus, the TReCASE model was applied to 14,414 genes.
First, the genome-wide gene-SNP pairs were scanned and the minimum-p SNPs were 
obtained. Figure 6(a) displays the Rsq distributions at the minimum-p SNPs by the 
TReCASE model with the MLE and IMP methods. Compared to MLE, IMP had a tendency 
to produce minimum-p SNPs with lower Rsq values. Since the ASE data generally stop 
providing reliable information on the cis-effect when Rsq ≤ 0.4, we filtered out the 
TReCASE results whose minimum-p SNPs had Rsq ≤ 0.4; such a quality-control (QC) 
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procedure can also relieve the burden of multiple comparisons. As a result, 71.0% and 
66.0% of minimum-p SNPs by MLE and IMP, respectively, passing the QC procedure.
Then, permutation p-values for the minimum-p SNPs were calculated. Figure 6(b) shows the 
numbers of minimum-p SNPs whose permutation p-values pass varying cutoffs. Such a plot 
can be used to compare the power of different methods for identifying eQTLs. It can be seen 
that the MLE method was uniformly more powerful than IMP at any cutoff. The relatively 
small power gain was expected because, for most minimum-p SNPs, the phases were 
predicted sufficiently well (Figure 6[a]). In particular, 53.3% and 48.0% of minimum-p 
SNPs by MLE and IMP, respectively, had Rsq ≥ 0.7. Due to the prevalence of eQTLs in the 
human genome, we do not expect the permutation p-values to follow a uniform distribution; 
the skewness of the histograms in Supplementary Figure S6 seems reasonable.
Next, we identified a total of 2,486 eQTLs by controlling for an FDR of 5%, and determined 
their cis or trans mechanisms using the cis-trans test at a nominal significance level of 0.01. 
Here, we chose a relatively stringent nominal significance level because we wish the test to 
be less sensitive to the difference between βA and βT, which should always exist in real data 
even for cis-eQTLs. As shown in Table 3, there were 141 genes that were identified with 
eQTLs by the TReC model but lack of the ASE data; as a result, the TReCASE model did 
not apply to these genes and the eQTLs were undetermined for the mechanism. There are 23 
eQTLs that were identified only by TReC; they are expected to be trans-eQTLs. The reason 
that 7 of them were determined to be cis is that the cis-trans test may lack power. There are 
1,876 eQTLs that were identified only by TReCASE; they are expected to be cis-eQTLs. 
The reason that 195 of them were determined to be trans is due to the difference between βT 
and βA in the real data. The dominant number of eQTLs that were identified only by 
TReCASE highlights the importance of exploiting the ASE data for cis-eQTL mapping. 
Furthermore, there were 410 genes identified with eQTLs by both models. In particular, the 
two models identified overlapping cis-eQTLs for 179 genes, different cis-eQTLs for 154 
genes, and one cis-eQTL and one trans-eQTL for 36 genes. A full list of the 2,486 eQTLs 
can be found in Supplementary Dataset S1.
At last, we compared the 2,486 eQTLs with the 134 SNPs found to be associated with breast 
cancer (referred to as trait-associated SNPs [TASs]) and downloaded from the NHLBI 
GWAS Catalog (Welter et al. 2014). One eQTL, rs4784227 with alleles C and T, was a 
TAS. The SNP was reported by Long et al. (2010) to have a highly significant association 
with breast cancer risk, with an odds ratio of 1.19 per T allele in European Americans. Our 
analysis identified the SNP to be a cis-eQTL for gene TOX3, with the effect of allele T 
consistently estimated to be −0.77 by either the ASE, TReC or TReCASE model. Since it 
has been established that TOX3 functions as a tumor suppressor in breast cancer cells 
(Cowper-Sal et al. 2012), our eQTL analysis suggested a putative functional role of 
rs4784227 on breast cancer risk, which has been confirmed in vivo in a breast cancer cell 
line (Cowper-Sal et al. 2012). Specifically, rs4784227 is located at a binding motif of the 
transcription factor FOXA1 and allele T of rs4784227 increases the binding affinity of 
FOXA1, which in turn represses the expression of TOX3. This cis-eQTL would also be 
identified using the TReCASE model with IMP, but not using the TReC model alone. In 
total, 6 eQTLs are in the vicinity (i.e., within 10 kb) of breast cancer TASs (Supplementary 
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Tables S5-S6), whereas only 3 are expected by chance, showing evidence of eQTL 
enrichment among TASs. Like rs4784227, these eQTLs also hold the potential to elucidate 
the functional roles of the nearby TASs.
5. DISCUSSION
In summary, we developed a powerful and timely tool for cis-eQTL mapping with RNA-seq 
data. We showed that the proposed approach is more powerful than the existing two-stage 
approach and the use of total gene expression alone. All the proposed methods are 
implemented in the R package XXX, which is publicly available at our website. With the 
empirical data from the TCGA, we demonstrated the ability of our approach to discover cis-
eQTLs and to elucidate the functional roles of nearby TASs, and the computational 
efficiency (e.g., only one day on 50 IBM HS22 machines to analyze the TCGA data) of our 
software to perform a genome-wide analysis. As functional genomics is rapidly progressing 
towards unraveling the cis-regulatory control of gene expression and many large-scale 
RNA-seq studies are underway, our analytical tool may play a key part in the coming years.
Our work significantly improves over the one by Sun (2012). First, we do not phase the 
candidate eQTL as a priori. Our maximum-likelihood methods phase the candidate eQTL 
and assess the cis-effect in an iterative fashion, and thus can remove the bias in the estimated 
effect size and boost the power in detecting a cis-eQTL. Second, we base our methods on 
score statistics and devise a permutation process that is tailored to the score statistics, 
thereby reducing the computation time to a mere ~5% of the time required the traditional 
permutation process. Third, for each SNP-gene pair, Sun (2012) adopted a strategy of first 
deciding on the cis or trans mechanism by the cis-trans test and then choosing the TReC or 
TReCASE model based on the test result. This strategy would incur a great computation cost 
because the computationally intensive cis-trans test has to be applied for every possible 
SNP-gene pair. In addition, it is unnatural to distinguish between the cis and trans 
mechanisms before any association is detected.
For the two-stage approach, we have used a small number of exonic SNPs to predict the 
phase of the candidate eQTL, so that the two-stage approach is compared with our 
maximum-likelihood approach on equal footing. An alternative is to use a hidden-Markov 
model (HMM) (Stephens et al. 2001; Browning and Browning 2009; Li et al. 2010; 
Delaneau et al. 2012), which exploits the LD information over a larger region, and thus may 
yield more accurate prediction of phase in certain situations. The conclusions regarding the 
relative merits of the maximum-likelihood approach versus the two-stage approach are 
expected to hold when an HMM is used.
We have assumed independence between the covariates X and the diplotype H, so that the 
probability Pr(X|H) factored out from the likelihood (2). This assumption is reasonable if the 
covariates include demographic variables, such as age and gender, and environmental 
exposures. If it is believed that X and H are correlated, then we can extend the methodology 
by adopting a generalized odds-ratio function for Pr(X|H) (Hu et al. 2010). Likelihoods (2) 
and (6) will then involve the (potentially infinite-dimensional) distribution function of X, 
which will greatly increase the theoretical and numerical complexity. In addition, assessing 
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the significance of the minimum-p SNP should then rely on the parametric bootstrap, instead 
of permutation.
We have focused on the minimum-p SNP for each gene. It is possible that other SNPs act 
independently on the gene expression, but to a lesser extent. To detect such SNPs, we can 
include the minimum-p SNP as a covariate and search for additional eQTLs conditional on 
the most significant one. Although it is straightforward to do so with the TReC model, it is 
less transparent with the ASE model. Not only the regression model (1) should include the 
minimum-p SNP as a covariate, but also the likelihood (2) should account for the phasing 
uncertainties of both SNPs.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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APPENDIX A: Rsq Measure of Phasing Accuracy
The development of Rsq follows the rational of Li et al. (2010) in developing a measure of 
accuracy for imputed SNP genotypes. First, for a candidate eQTL and  exonic SNPs, we 
estimate the corresponding π by maximizing the likelihood that uses the genotype data only:
(7)
Due to the missing Hi, the expectation-maximization (EM) algorithm is the method of 
choice for the maximization. In the E-step, we evaluate
and in the M-step, we update πk by , where I(.) is the indicator function, i 
= 1, …, N, and k, l, k∗, l∗ = 1, …, K. Denote the maximum likelihood estimator (MLE) of π 
by . Then, for an individual with G = 1 and , we can estimate G1 by the 
expected number of allele 1 on the same chromosome as , i.e., 
 where the subscript (1, m) represents the 
haplotype consisting of allele 1 at the candidate eQTL and  at the exonic SNPs. Although 
 is not a form of phasing due to the continuous nature, it is an unbiased estimator of G1. 
To quantify the phasing accuracy, a natural measure would be the Pearson correlation 
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coefficient r2 between  and the underlying G1. Since G1 is unknown, we estimate r2 by 
the ratio of the sample variance of  with what would be expected if G1 was observed (Li 
et al. 2010), and refer to the estimated r2 as the Rsq measure. Specifically, 
. Write 
. By simple algebra, we show that 
, and . By the 
symmetry of the two haplotypes, E(G1|G = 1) = 0.5, E( |G = 1) = 0.5, and thus Var(G1|G = 
1) = 0.25. In summary, we develop a measure of phasing accuracy to be
We note that the calculation of Rsq, though involving an iterative process to solve for , is 
computationally fast and scalable to the genome-wide scan.
APPENDIX B: Maximum Likelihood Inference
B.1 Inference for ASE model
We obtain the MLEs of βA, ψ, and π based on the likelihood (2) via the following EM 
algorithm. The complete-data log-likelihood is
In the E-step, we evaluate E[I{Hi = (hk, hl)}|R1i, Ri, Gi, ], which can be shown to be
(8)
In the M-step, we maximize lA(βA, ψ, π) with I{Hi = (hk, hl)} replaced by ωikl. Specifically, 
we update πk, k = 1, …, K, by
(9)
and update βA and ψ by a one-step Newton-Raphson iteration. Starting with βA = 0, ψ = 0 
and π = , where  is the MLE based on the likelihood (S1), we iterate between the E-step 
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and M-step until the change in the observed-data log-likelihood is negligible. Denote the 
MLEs of βA, ψ, and π by , and .
We can estimate the standard errors of , and  by the Louis formula (Louis 1982). 
Write Ck,l,j = pk,l + jψ, Dk,l,j = 1 − pk,l + jψ, and Ik,l = I(hk = hl), where pk,l was defined in 
expression (1). For i = 1, …, N and k, l = 1, …, K, calculate the vector
Calculate the block diagonal matrix ikl with two blocks. The first block is a 2×2 matrix with 
two diagonal elements,
and
and an off-diagonal element
The second block is a (K − 1) × (K − 1) matrix
where E(K−1)×(K−1) is a (K − 1) × (K − 1) matrix with all elements being 1. For subjects with 
Ri = 0, the elements in ikl and ikl associated with the derivative with respect to βA or ψ are 
zero. The covariance matrix for  is given by , where
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and ν′ denotes the transpose of the vector ν. Note that ωikl, ikl and ikl should be evaluated at 
the MLEs. The standard errors for , and  are the square-roots of the 
diagonal elements in ΣA. The standard error for  is the square root of 
(1, …, 1)B(1, …, 1)′, where B is the last (K − 1) × (K − 1) sub-matrix of ΣA.
To calculate the score statistic for testing H0 : βA = 0, we first produce the restricted MLE of 
the nuisance parameter , denoted by . 
The  turn out to be the MLEs based on the likelihood (7), and  maximizes 
. Then, the score and information functions for (βA, δ′)′, which 
take the forms  and IA, respectively, are evaluated at (0, )′. Based on the 
partition
where β represents βA, the score statistic n−1/2UA,β is asymptotically zero-mean normal with 
a variance that can be consistently estimated by n−1 {IA,ββ − IA,βδ IA,δβ}.
B.2 Inference for TReC model
The MLEs of βT, γ, and φ, denoted by , and , based on the likelihood (5) can be 
obtained via the Newton-Raphson algorithm with the first and negative second derivative of 
lT(βT, γ, φ) = log{LT(βT, γ, φ)}, denoted by UT and IT. The covariance matrix for 
is given by , which is evaluated at the MLEs.
To calculate the score statistic for testing H0 : βT = 0, we first produce the restricted MLEs 
of the nuisance parameter ξ = (γ, φ)′, denoted by . Then, the score and 
information functions for (βT, ξ′)′, which take the forms UT and IT, respectively, are 
evaluated at (0, )′. Based on the partition
where β represents βT, the score statistic n−1/2UT,β is asymptotically zero-mean normal with 
a variance that can be consistently estimated by n−1 {IT,ββ − IT,βξ IT,ξβ}.
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B.3 Inference for TReCASE model
Let β = βA = βT. The MLEs of β, δ, and ξ based on the likelihood (6) can be obtained via a 
similar EM algorithm as for the ASE model. The complete-data log-likelihood is lTA(β, δ, ξ) 
= lA(β, δ) + lT(β, ξ). In the E-step, we evaluate the ωikl in (8). In the M-step, we update πk, k 
= 1, …, K, by the  in (9) and update β, ψ, and ξ by a one-step Newton-Raphson 
iteration. Denote the MLEs of β, δ, and ξ by , and . According to their definitions, 
 and , as they are MLEs for different models. The 
covariance matrix for  is given by , where
To calculate the score statistic for testing H0 : β = 0, we first obtain the restricted MLEs for 
the nuisance parameter τ = (δ′, ξ′)′ to be , where  and  are restricted MLEs 
from the ASE and TReC models, respectively. Then, the score and information functions for 
(β, τ′)′, which take the forms UTA = (UA,β + UT,β, U′Aδ, U′T,ξ)′ and ITA, respectively, are 
evaluated at (0, )′. The score statistic and the variance estimator can be constructed in the 
same fashion as for the ASE model.
B.4 Cis-trans test
Let βA = β and βT = β + α. To calculate the score statistic for testing H0 : α = 0, we first 
obtain the restricted MLEs for the nuisance parameter τ∗ = (β, τ′)′ to be 
 where  and  are the MLEs of β, δ, and ξ, respectively, from the 
TReCASE model. The score and information functions for (α,(τ∗)′)′ take the forms
respectively, which are evaluated at (0, ( ∗)′)′. The score statistic and the variance estimator 
can be constructed in the same fashion as for the ASE model.
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A hypothetical example of cis-eQTL mapping, adapted from Sun (2012). (a) RNA-seq 
measurements of a hypothetic gene with two exons for three diploid individuals. Because 
individuals (i) and (ii) have at least one exonic SNPs showing a heterozygous genotype, they 
have non-zero ASE measurements. In addition, only individual (i) has a heterozygous 
genotype at the candidate eQTL, so association analysis using ASE is only possible within 
individual (i). (b) The ASE measurements for individual (i). (c) The TReC for the three 
individuals.
HU et al. Page 20














A five-step pipeline for performing a genome-wide analysis of cis-eQTLs. TReCASE, TReC 
and ASE are models that are used in parallel in certain steps.
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Power of the TReCASE model for testing a cis-eQTL in the first simulation study. The 
nominal significance level is 0.05. Each power estimate is based on 10,000 replicates.
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Power of the TReCASE model for detecting a cis-eQTL in the second simulation study. Rsq 
is the average phasing accuracy of the minimum-p SNPs yielded by MLE. The nominal 
significance level is 0.05. Each power estimate is based on 1,000 replicates.
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Type I error of the cis-trans test in the third simulation study. The nominal significance level 
is 0.05. Each estimate of type I error rate is based on 10,000 replicates.
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Results in the analysis of the TCGA data. (a) Distribution of the Rsq values at minimum-p 
SNPs. (b) Numbers of minimum-p SNPs with permutation p-values passing varying p-value 
cutoffs at a − log10 scale. MLE and IMP are the maximum-likelihood and two-stage 
methods, respectively, with the TReASE model. TReC is the TReC model.
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Table 3
Genes identified with eQTLs at an FDR of 5% in the TCGA Data
Test results Genes
TReC TReCASE (MLE) cis-trans no.
yes NA NA 141
yes no cis 7
trans 16
no yes cis 1681
trans 195





NOTE: TReC is the TReC model. TReCASE (MLE) is the TReCASE model with the MLE method. Yes and no indicate that the minimum-p SNP 
is declared as significant and nonsignificant, respectively, by FDR control. NA is not applicable. cis-trans is the cis-trans test. If two different 
eQTLs within a gene are identified by TReC and TReCASE, their mechanisms are separated by a comma and unordered.
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